654 related articles for article (PubMed ID: 33713370)
21. Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase.
Montastruc F; Palmaro A; Bagheri H; Schmitt L; Montastruc JL; Lapeyre-Mestre M
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1556-65. PubMed ID: 26256010
[TBL] [Abstract][Full Text] [Related]
22. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
[TBL] [Abstract][Full Text] [Related]
23. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
24. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
[TBL] [Abstract][Full Text] [Related]
25. Risperidone-induced Somnambulism: A Case Report and Brief Review of Literature.
Najmi A; Siddiqui F; Ray A; Jhaj R; Sadasivam B
Cureus; 2020 Mar; 12(3):e7238. PubMed ID: 32284914
[TBL] [Abstract][Full Text] [Related]
26. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
27. Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in vigibase.
De Las Cuevas C; Sanz EJ; Villasante-Tezanos AG; de Leon J
Expert Opin Drug Metab Toxicol; 2023 Feb; 19(2):57-74. PubMed ID: 36920343
[TBL] [Abstract][Full Text] [Related]
28. Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions.
Hägg S; Bate A; Stahl M; Spigset O
Drug Saf; 2008; 31(8):685-94. PubMed ID: 18636787
[TBL] [Abstract][Full Text] [Related]
29. Comparative Effects of 30 Antipsychotics on Risk of Catatonia: An Analysis of the WHO Pharmacovigilance Database.
Da Costa J; Very E; Rousseau V; Virolle J; Redon M; Taïb S; Revet A; Montastruc F
J Clin Psychiatry; 2022 Dec; 84(1):. PubMed ID: 36516322
[No Abstract] [Full Text] [Related]
30. Weight Gain During Antipsychotic Treatment in Children, Adolescents, and Adults: A Disproportionality Analysis in the Global Pharmacovigilance Database, Vigibase
Kaguelidou F; Valtuille Z; Durrieu G; Delorme R; Peyre H; Treluyer JM; Montastruc F; Chouchana L
Drug Saf; 2023 Jan; 46(1):77-85. PubMed ID: 36459374
[TBL] [Abstract][Full Text] [Related]
31. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database.
Nguyen LS; Cooper LT; Kerneis M; Funck-Brentano C; Silvain J; Brechot N; Hekimian G; Ammirati E; Ben M'Barek B; Redheuil A; Gandjbakhch E; Bihan K; Lebrun-Vignes B; Ederhy S; Dolladille C; Moslehi JJ; Salem JE
Nat Commun; 2022 Jan; 13(1):25. PubMed ID: 35013204
[TBL] [Abstract][Full Text] [Related]
32. Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.
Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
J Clin Psychiatry; 2006 Jul; 67(7):1055-61. PubMed ID: 16889448
[TBL] [Abstract][Full Text] [Related]
33. Adverse reactions to antipsychotics in Parkinson disease: an analysis of the Spanish pharmacovigilance database.
Lertxundi U; Ruiz AI; Aspiazu MÁ; Domingo-Echaburu S; García M; Aguirre C; García-Moncó JC
Clin Neuropharmacol; 2015; 38(3):69-84. PubMed ID: 25970275
[TBL] [Abstract][Full Text] [Related]
34. Neurocognitive Disorders Associated with PCSK9 Inhibitors: a Pharmacovigilance Disproportionality Analysis.
Gouverneur A; Sanchez-Pena P; Veyrac G; Salem JE; Bégaud B; Bezin J
Cardiovasc Drugs Ther; 2023 Apr; 37(2):271-276. PubMed ID: 34436707
[TBL] [Abstract][Full Text] [Related]
35. Association of First- vs. Second-Generation Antipsychotics with Lipid Abnormalities in Individuals with Severe Mental Illness: A Systematic Review and Meta-Analysis.
Buhagiar K; Jabbar F
Clin Drug Investig; 2019 Mar; 39(3):253-273. PubMed ID: 30675684
[TBL] [Abstract][Full Text] [Related]
36. Safety Profile of Sclerosing Agents: An Analysis From the World Health Organization Pharmacovigilance Database VigiBase.
Roselli A; Khouri C; Roustit M; Blaise S; Cracowski JL
Dermatol Surg; 2019 Dec; 45(12):1517-1528. PubMed ID: 30829775
[TBL] [Abstract][Full Text] [Related]
37. Sleep-related eating disorder induced by olanzapine.
Paquet V; Strul J; Servais L; Pelc I; Fossion P
J Clin Psychiatry; 2002 Jul; 63(7):597. PubMed ID: 12143918
[No Abstract] [Full Text] [Related]
38. A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.
Gao K; Ganocy SJ; Gajwani P; Muzina DJ; Kemp DE; Calabrese JR
J Clin Psychiatry; 2008 Feb; 69(2):302-9. PubMed ID: 18211129
[TBL] [Abstract][Full Text] [Related]
39. Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.
Kimura G; Kadoyama K; Brown JB; Nakamura T; Miki I; Nisiguchi K; Sakaeda T; Okuno Y
Int J Med Sci; 2015; 12(2):135-40. PubMed ID: 25589889
[TBL] [Abstract][Full Text] [Related]
40. Low dose quetiapine in the treatment of an adolescent with somnambulism: a case report.
Gill JS; Pillai SK; Koh OH; Jambunathan ST
Acta Neurol Belg; 2011 Jun; 111(2):155-6. PubMed ID: 21748939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
